Medtronic Receives Category I CPT® Code Approvals for Altaviva™ and Symplicity Spyral™ Systems
PR Newswire•01/10/2026•16:00 ET
0
Key Highlights
- ➤AMA approves permanent Category I CPT codes for Medtronic (MDT) Altaviva and Symplicity Spyral systems
- ➤New CPT codes replace Category III codes, effective January 2028
- ➤Medicare finalized coverage for Symplicity Spyral renal denervation in October 2025
- ➤FDA approved Altaviva for urge urinary incontinence in September 2025
Expert Statements
Lindsay Bockstedt, Vice president of health economics, policy, and reimbursement at Medtronic
“These Category I approvals reflect the robust clinical evidence and physician adoption for innovative solutions addressing critical gaps in care and unmet patient needs.”
Lindsay Bockstedt, Vice president of health economics, policy, and reimbursement at Medtronic
“The decision by AMA represents meaningful progress in the reimbursement pathway for these technologies, as Medtronic remains committed to reducing barriers to broader adoption and patient access. We're grateful to the stakeholders and clinical community whose work made this possible.”
Medtronic Receives Category I CPT® Code Approvals for Altaviva™ and Symplicity Spyral™ Systems PR Newswire
Coding approvals reflect growing clinical evidence and physician adoption of Medtronic solutions addressing urge urinary incontinence and hypertension
Get started
Create a free account to read the full story.